statistiche ricercatore

Continente	#
EU - Europa	337
AS - Asia	297
NA - Nord America	93
SA - Sud America	37
AF - Africa	9
Continente sconosciuto - Info sul continente non disponibili	1
OC - Oceania	1
Totale	775

Nazione	#
IT - Italia	189
SG - Singapore	175
US - Stati Uniti d'America	89
CN - Cina	71
FR - Francia	53
RU - Federazione Russa	50
BR - Brasile	33
HK - Hong Kong	18
NL - Olanda	12
VN - Vietnam	12
CH - Svizzera	9
KR - Corea	7
PL - Polonia	6
BD - Bangladesh	4
HU - Ungheria	4
DE - Germania	3
GB - Regno Unito	3
IN - India	3
SE - Svezia	3
ZA - Sudafrica	3
BE - Belgio	2
CI - Costa d'Avorio	2
IE - Irlanda	2
JP - Giappone	2
MX - Messico	2
AU - Australia	1
CA - Canada	1
CO - Colombia	1
CR - Costa Rica	1
EC - Ecuador	1
EE - Estonia	1
EG - Egitto	1
ID - Indonesia	1
IL - Israele	1
IQ - Iraq	1
JO - Giordania	1
KE - Kenya	1
KZ - Kazakistan	1
MZ - Mozambico	1
PE - Perù	1
RE - Reunion	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	775

Nome	#
L’evoluzione delle politiche immigratorie in Italia	349
Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme	83
Interaction of VIVO-8-hydroxyquinoline species with RNase A: the effect of metal ligands in the protein adduct stabilization	81
Stabilization and Binding of [V4O12]4− and Unprecedented [V20O54(NO3)]n− to Lysozyme upon Loss of Ligands and Oxidation of the Potential Drug VIVO(acetylacetonato)2	67
Spectroscopic/Computational Characterization and the X-ray Structure of the Adduct of the VIVO-Picolinato Complex with RNase A	55
Binding to Lysozyme of the Pharmacologically Active VIVO−Pyridinone Drug	20
Binding of [VIVO(8-HQ)(H2O)]+ to the model protein lysozyme: structural and computational studies	20
Binding to proteins of the pharmacologically active bis(maltolato)oxidovanadium(IV)	20
Binding to lysozyme of VIVO−pyranonato and VIVO−pyridinone	19
Non-covalent Interactions with Proteins of Potential Vanadium Drugs: The Case of the Lysozyme/VIVO-8-hydroxyquinoline adduct	19
Binding of oxidovanadium(IV) complexes [VIVO(malt)2] and [VIVO(empp)2] to lysozyme	17
X-ray structures of adducts formed upon reaction of lysozyme with a vanadate complex of 1,2-dimethyl-3-hydroxy-4(1H)-pyridinone	16
Protein‐Protein Stabilization in VIVO/8‐Hydroxyquinoline–Lysozyme Adducts	16
Interaction of the pharmacologically active VIVO−Pyridinone drug with the model protein lysozyme	15
Totale	797

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	3	0	0	0	0	0	0	0	1	0	0	0	2
2022/2023	14	1	0	0	0	0	0	0	3	0	0	0	10
2023/2024	60	0	2	19	1	2	5	4	5	5	6	9	2
2024/2025	291	7	18	22	6	15	20	31	13	40	26	62	31
2025/2026	429	50	50	53	108	143	25	0	0	0	0	0	0
Totale													797